In the serum of mice with tumours induced by the Gross strain of mouse leukaemia virus (MLV-G), both type and group specific antigens, corresponding to the separate specificities of the Gross cell surface antigen (GCSA), have been identified in serum (Aoki et al., 1972) . The intraviral group specific antigen, p30, has been detected by serology and by inhibition of in vitro cell mediated cytotoxicity, on the cell surface and in the serum of rats carrying Gross lymphomata (Knight, Mitchison and Shellam, 1975) .
Serum from animals with tumours induced by oncornaviruses contains blocking factors which inhibit antibody and cell mediated immunity in vitro Hellstrom and Hellstrom, 1969; Gorczynski and Knight, 1975) . In the rat Gross lymphoma system, the question of whether p30 blocks as free antigen or as antigen-antibody coinplex has not been resolved . In the serum of mice with tumours induced by Moloney murine sarcoma virus, only complexes of antibody with a small * T'his work was performed whhie L.B.E. was on a sabbatical leave from the Cancer Research Institute, mnolecular weight component, presumably antigen, are inhibitory (Sjogren et al., 1971; Gorczynski et al., 1975) .
In a previous paper we demonstrated that antigenic determinants of the most abundant internal virion protein of the C type RNA viruses, p30, are present on the surface of spleen cells from mice bearing Moloney leukaemia and on an in vitro cell line derived from a Moloney sarcoma virus (MSV-M) induced tumour (MSC) (Epstein and Knight, 1975) . Complement dependent antibody mediated cytotoxicity was Lused as the technique for detection of the antigenic determinants of p30, using an antiserum (ILR-3) prepared in rats against a syngeneic Moloney virus (MLV-M)-induced lymphoma and a goat antiserum (goat anti-gs3) prepared against disrupted feline leukaemia virus (FeLV) . Both antisera were cytotoxic for Moloney leukaemia spleen cell (M) and MSC targets and in each instance the cytotoxicity was at least partially absorbed by purified preparations of p30.
The purpose of the present study was to determine if antigenic determinants of the p30 molecule could be detected in sera of Balb/c mice bearing Moloney leukaemia by using such sera to block the antibody mediated cytotoxic reactions agaiinst both types of target cells.
MATERIALS AND METHODS
Details concerning the source and maintenance of Balb/c mice, passage of Moloney leukaemia in vivo and MSC cells in vitro, preparation of antisera and rabbit complement and performance of the 5'Cr release antibody mediated cytotoxicity test are described in the previous paper (Epstein and Knight, 1975 Absorption of antisera with mouse sera.-Various volumes of mouse serum (5-50 ,ul) were combined with either neat Rat ILR-3 or goat anti-gs3 and sufficient medium (Dulbecco's modification of Eagle's medium with glutamine (E-4-G1) supplemented with 10% normal rat or goat serum) to bring the antiserum to the dilution required in a final volume of 0-1 ml. The xenogeneic serum mixtures were kept at room temperature for 30 min and then employed in the 5ICr release assay.
Antibody cytotoxicity assay.-Either M leukaemia spleen cells (5 x 105 viable) or MSC cells (1 x 105 viable) were used as targets in the assay and were labelled with 5'Cr as described previously (Epstein and Knight, 1975) . For each assay total 5tCr label, spontaneous 51 Cr release and maximum release by Brij detergent (polyoxyethylene lauryl ether, Pierce Chemical Co., U.S.A.) were determined. In addition, control tubes were prepared to determine the effect of rabbit complement (1: 3), E-4-GI with 10% normal rat or goat serum, normal or leukaemic mouse serum, and combinations of these on 5'Cr release. The formulae for calculating 00 specific cytotoxicity and 0% block are ex5r-14 plained in detail in the previous paper (Epstein and Knight, 1975 The formula for calculating %0 block is described in Materials and Methods in the previous paper (Epstein and Knight, 1975 Two representative experiments are depicted in Fig. 4 . For these experiments sera obtained from 2 separate groups of animals were tested against the same target cells. The mean % specific cytotoxicity of a 1/10 dilution of Rat ILR-3 for the MSC targets was 32/o. The data indicate that increasing amotnts of spun leukaemic serum results in increasing block of cytotoxicity of Rat ILR-3 for MSC targets. Both control sera blocked the reaction to about the same extent as Day 3 or Day 4 leukaemic serum. However, leukaemic serum taken after 4 days uniformly blocked the reaction considerably more than control serum.
In the experiments depicted in Fig 7 or 8 day serumn to block the cytotoxic reaction of Rat ILR-3. In Fig. 4 VIEA determinants may be present in unspun leukaemic serum and on the surface of M targets. We have not studied this antiserum with MSC targets. Since our previous study (Epstein and Knight, 1975) (Epstein and Knight, 1975) indicated that this antiserum could detect antigenic determinants of p30, the most abundant internal virion protein of the C type RNA viruses on the surface of both of these targets. We found that as little as 0418 ,/g of a purified preparation of p30 obtained by isoelectric focusing could block 4300 of the cytotoxicity of this antiserum for MSC targets and 10000 of its cytotoxicity for M targets. Thus, the fact that leukaemic sera could also block thase cytotoxic reactions suggested that the antigenic determinants of p30 were components of leukaemic serum, as well as being present on the surface of the target cells. Additional supportive evidence for the presence of p30 in leukaemic sera comes from our observation herein that leukaemic sera can also absorb cytotoxic antibody recognizing the interspecies group specific determinant (gs3) of the p30 molecule. The ability to block this reaction was maximum 7 days after the mice received leukaemic cells and then seemed to decline by 12 days. The decline in levels or accessibility of p30 seen in leukaemic serum at 12 days parallels that which we previously observed for the presence or accessibility of antigenic determinants of p30 on the surface of spleen cells taken from Moloney leukaemic animals (Epstein and Knight, 1975) . The ability of a given number of such spleen cells to absorb the cytotoxic antibody activity of the goat anti-gs3 was maximum at Day 8, and declined by Day 12.
In the present study we also observed that leukaemic sera from which viral particles were removed by centrifugation could also block the cytotoxic reaction of Rat ILR-3 and goat anti-gs3. That virus was present in the sera of the animals bearing leukaemia was established by observing viral particles by electron microscopy in the pelleted material of leukaemic sera subjected to high speed centrifugation. Virus was first detected in sera from animals who received leukaemic cells 8 days previously, and by 12 days after passage of the leukaemia viral particles had markedly increased. Thus, the presence of the group specific internal virion protein, p30, in Moloney leukaemic sera and on leukaemic cells reaches a maximum level by Day 7-8 and declines, and thereafter intact virus particles are detectable and continue to increase in number. These time course relationships are consistent with assembly and production of new virus at the cell surface and release into the circulation. It is also of interest that the maximum levels of p30 are seen in the sera and on leukaemic cells at a time when maximum rate of growth of the leukaemia occurs.
Elimination of viral particles from leukaemic sera by centrifugation had no depressive effect on the ability of the sera to absorb the cytotoxic activity of Rat ILR-3 against MSC targets. This suggests that the internal virion protein, p30, present in both spun and unspun preparations was the major substance responsible for block in that system. This is compatible with our previous observations that for a given number of MSC targets the amount or accessibility of p30 for cytotoxic reactions was greater than that observed for M targets (Epstein and Knight, 1975) . We showed that a given amount of purified p30 blocked the reaction of Rat ILR-3 against M targets more completely than that against MSC targets, where presumably there was more antigen to block.
In contrast, elimination-of viral particles from leukaemic sera did have a depressive effect on the ability of the virus free sera to absorb the cytotoxicity of Rat ILR-3 for M targets. Virus free sera were still capable of blocking (Fig. 3) (Moloney, 1962) and the control mice used in the present study were kept even further away in separate cages. Further, we found no electron microscopic evidence of virus in pelleted material obtained from normal serum subjected to high speed centrifugation, thus ruling out the possibility of active viral infection in the control mice. In addition, the stability to storage at -20°C of the material in control sera was less than that of the p30 in leukaemic serum. It is of interest that Abelev and Elgort (1970) , using an indirect immunoautoradiographic technique, found trace quantities of group specific internal virion antigens of murine leukaemia viruses in the sera of normal mice of one strain of low leukaemia incidence (i.e. C57B1/6), but not in the serum of Balblc mice, also considered to be a low leukaemia incidence strain. Further characterization of the material found in normal Balb/c sera in the present study would therefore be of interest. Recently, Shellam and Knight (1974) demonstrated that serum from rats bearing progressively growing Gross virus induced syngeneic lymphomata will block T lymphocyte cytotoxicity for tumour targets. p30 is also implicated in this system, as these same authors have shown that purified preparations of the protein can partially block T cell cytotoxicity and completely block syngeneic antibody mediated cytotoxicity .
Thus, in this and in a previous paper (Epstein and Knight, 1975) we have defined a system in which a group specific internal virion protein is associated with and serves as a cytotoxic target on the surface of Moloney virus infected or transformed cells, and is present in the sera of mice bearing Moloney leukaemia. Whether p30 serves to abrogate host defence mechanisms in vivo as well as in vitro and in what form it exists in the sera, i.e. as free antigenic determinants or antigen-antibody complexes remains to be established.
